Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
EPA Plans New Safety Regulations for Asbestos, Phthalates in 2023 The new rules include restrictions on chrysotile asbestos, exposure to which can increase the risk of mesothelioma, asbestosis and lung cancer. January 25, 2023 Martha Garcia Add Your Comments The U.S. Environmental Protection Agency (EPA) has announced plans to provide new safety rulings about chrysotile asbestos and other toxic chemicals this year, as part of an updated agenda that outlines actions the regulatory officials will focus on over the next twelve months. Under the Toxic Substances Control Act (TSCA), the agency is required to issue a comprehensive agenda twice a year, to explain upcoming or recently completed regulatory actions. On January 4, the EPA issued it’s Fall 2022 Unified Agenda, which outlines safety rulings, regulatory actions and two chemical-specific rule makings that will be addressed this year. New Asbestos Restrictions In 2021, the EPA issued a final risk evaluation for chrysotile asbestos, indicating that its use posed an unreasonable risk to consumers, workers, and bystanders. The EPA then proposed a rule on April 12, 2022 to address the unreasonable risk of injury to health linked to chrysotile asbestos. The new Unified Agenda proposes new restrictions on chrysotile asbestos that will prohibit the manufacture, import, processing, distribution, and commercial use of chrysotile asbestos for diaphragms used in the chloralkali industry. The ban includes the use of chrysotile asbestos in a range of products, including chrysotile asbestos-containing sheet gaskets used in chemical production, chrysotile asbestos-containing brake blocks used in the oil industry, aftermarket automotive chrysotile asbestos-containing brakes/linings, chrysotile asbestos vehicle friction products, and other chrysotile asbestos-containing gaskets. The proposed rule would also prohibit the manufacture, import, processing, and distribution of aftermarket automotive chrysotile asbestos-containing brakes/linings for consumer use and other chrysotile asbestos-containing gaskets for consumer use. The EPA plans to review public comments and issue a final rule in October 2023. The new agenda also calls for regulations for disposal and record-keeping requirements for the manufacturing of chrysotile asbestos-containing products under the TSCA. The rulemaking would require manufacturers of asbestos-containing products to report exposure-related information, quantities of asbestos, and asbestos-containing articles to the EPA, which would use the information to determine future regulations of asbestos and plans to issue a final rule in May 2023. Asbestos Health Risks The risks of asbestos exposure are well documented, and most modern, first-world countries banned asbestos use in its entirety decades ago. But not the United States. The EPA’s determination of asbestos risks follows decades-long mesothelioma litigation, which is often referred to as the longest running mass tort in the history of the United States. Asbestos lawsuits have been filed by more than 600,000 people against approximately 6,000 defendants, all raising similar allegations that manufacturers and sellers of products containing asbestos knew about the risk of mesothelioma and other asbestos injuries, yet failed to provide adequate warnings. Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Mesothelioma Lawsuits Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION DINP Added to Toxic Chemicals List The other chemical included in the Fall 2022 agenda was Diisononyl Phthalate (DINP), with the EPA issuing a proposed rule to add DINP to the list of toxic chemicals subject to reporting requirements. On August 15, 2022, the EPA proposed adding DINP to the toxic chemical list and requested comment on the updated DINP hazard assessment. The agency indicates it will issue a final rule in May 2023. DINP is a plasticizer used in a wide variety of plastic products. The EPA has determined the chemical meets the EPA’s toxicity criteria because it can reasonably be anticipated to cause cancer and serious or irreversible chronic health effects in humans. The chemical has been linked to developmental disorders, kidney toxicity and liver toxicity, according to the EPA. Other Fall 2022 Agenda items included updating final rules for a list of various chemicals, updates to procedures for chemical risk evaluations, revisions to the TSCA, new use rules for phthalates, flame retardants and other solvents, and fee updates for regulatory actions linked to proposed rules and updates. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Asbestos, Asbestos Exposure, Chemicals, EPA, Mesothelioma, Phthalates More Mesothelioma Lawsuit Stories EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024 EPA Bans Last Uses of Toxic Asbestos in the United States March 19, 2024 U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: today) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025) Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024
U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024
Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: today) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: yesterday) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: 2 days ago) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)